Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: reply

J Thromb Haemost. 2018 Jan;16(1):185-188. doi: 10.1111/jth.13876. Epub 2017 Nov 18.

Authors

C Delierneux¹, N Donis¹, L Servais¹, O Wéra¹, P Lancellotti^{1

2}, C Oury¹

Affiliations

¹ Department of Cardiology, Laboratory of Thrombosis and Hemostasis and Valvular Heart Disease, GIGA-Cardiovascular Sciences, University of Liege, CHU Sart-Tilman, Liege, Belgium.
² Anthea Hospital, Gruppo Villa Maria Care and Research, Bari, Italy.

PMID: 29052966
DOI: 10.1111/jth.13876

No abstract available

Publication types

Letter
Comment

MeSH terms

Lectins, C-Type*
Oligodeoxyribonucleotides*
Platelet Activation

Substances

Lectins, C-Type
Oligodeoxyribonucleotides